Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Adv Healthc Mater. 2013 Mar 12;2(10):1322–1328. doi: 10.1002/adhm.201300002

Figure 4.

Figure 4

In vivo antimicrobial activity of LipoLA against P. acnes through intradermal injection. Different concentrations of LipoLA (2, 4, 6, or 8 mg/mL) were mixed with P. acnes and immediately injected into mouse ears (n=6 per group), followed with bacteria quantification at 24 h. BPO (16 mg/mL) was used as a positive control. PBS and none P. acnes inoculation were served as negative controls. Data represents mean ± SD of three independent experiments. UD: undetectable.